Status:
COMPLETED
Early Diagnosis of Kidney Damage Associated With Tobacco Use
Lead Sponsor:
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Collaborating Sponsors:
Instituto de Investigación Biomédica de Salamanca
Grupo de Investigación de Atención Primaria de Castilla y León
Conditions:
Kidney Injury
Kidney Disease, Chronic
Eligibility:
All Genders
18-99 years
Brief Summary
Tobacco consumption is associated with the appearance of several pathologies, the best known are Chronic Obstructive Pulmonary Disease, several types of cancer and cardiovascular diseases. However, th...
Detailed Description
According to the WHO, smoking is the main cause of preventable disease and death, being a known risk factor for the development of cancer, respiratory diseases, cardiovascular diseases, etc. Despite t...
Eligibility Criteria
Inclusion
- Patients of legal age who agree to participate in the study and do not comply with any of the exclusion criteria
Exclusion
- Patients who are terminally ill; presenting previously diagnosed renal failure
- Patients that during the week prior to the sample collection, or at the time of the sample, have been treated with any of the following drugs: aminoglycosides, cephalosporins, tetracyclines, amphotericin B, cisplatin, cyclosporine, foscarnet, acyclovir, cidofovir, radiological contrasts or any other potentially nephrotoxic drug.
- Patients who do not wish to sign the informed consent
Key Trial Info
Start Date :
March 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03850756
Start Date
March 4 2019
End Date
July 1 2022
Last Update
March 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Salud La Alamedilla
Salamanca, Spain
2
Unidad de tabaquismo del CAUSA
Salamanca, Spain